Financial statements Hanke Tissue
Balance sheet data of HANKE TISSUE
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 220 222 605,00 | 203 520 182,48 |
| A. Fixed assets | 122 476 523,54 | 119 817 282,81 |
| B. Current assets | 97 746 081,46 | 83 702 899,67 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 220 222 605,00 | 203 520 182,48 |
| A. Equity | 110 349 824,52 | 104 670 197,84 |
| B. Liabilities and provisions for liabilities | 109 872 780,48 | 98 849 984,64 |
| I. Long-term liabilities | 25 269 378,79 | 10 623 792,66 |
| II. Short-term liabilities | 80 344 305,74 | 85 039 943,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.